Charles B. Haaser
VP of Finance, Chief Accounting Officer & TreasurerMr. Charles B. Haaser has been Chief Accounting Officer at Metabolix, Inc. (now, Yield10 Bioscience, Inc.) since November 03, 2014 and has been its Vice President of Finance since October 2016. Mr. Haaser serves as Principal Financial Officer at Yield10 Bioscience, Inc. He served as Corporate Controller of Metabolix, Inc. since 2008 until October 2016 and has been its Treasurer since November 2014. Mr. Haaser served as Acting Chief Financial Officer at ABIOMED Inc. from February 2003 to 2006 and as Corporate Controller from 1998 to 2006 and Principal Accounting Officer from 1998 to May 2006. From 1997 to 1998, Mr. Haaser was Controller for Technical Communications Corporation ABIOMED Inc. Before joining Metabolix, Mr. Haaser was the Corporate Controller of Indevus Pharmaceuticals, Inc. from 2006 to 2008. From 1984 to 1986, Mr. Haaser was an auditor in the commercial audit division of Price Waterhouse LLP (now PricewaterhouseCoopers LLP). He has experience in accounting and finance, primarily working for publicly traded U.S. companies. He has been with Metabolix, Inc. since 2008 From 1986 to 1997, he was employed as Director of Finance by ISI Systems, Inc. From 1984 to 1986, Mr. Haaser was employed by the commercial audit division of Price Waterhouse LLP. He received a Bachelors degree in Business Administration (Finance) from the University of Notre Dame, an MBA from Northeastern University and a Masters of Science in Taxation from Bentley College. Mr. Haaser became a Certified Public Accountant in 1997.
Positions
- Company NameYield10 Bioscience, Inc.Stock CodeYTENQPositionVP of Finance, Chief Accounting Officer & Treasurer
